New York-listed medical device maker Edwards Lifesciences has acquired one of its corporate venturing portfolio companies, Embrella Cardiovascular, for $43m in cash.
Embrella raised $6.7m in its series B round in August 2008 from Edwards and venture capital firms BioStar Ventures, MedFocus Fund and Hatteras Venture Partners.